The organic constituents of exhaled human breath are representative of blood-borne concentrations through gas exchange in the blood/breath interface in the lungs. The presence of specific compounds can be an indicator of recent exposure or represent a biological response of the subject. For volatile organic compounds (VOCs), sampling and analysis of breath is preferred to direct measurement from blood samples because breath collection is noninvasive, potentially infectious waste is avoided, and the measurement of gas-phase analytes is much simpler in a gas matrix rather than in a complex biological tissue such as blood. To exploit these advantages, we have developed the "single breath canister" (SBC) technique, a simple direct collection method for individual alveolar breath samples, and adapted conventional gas chromatography-mass spectrometry analytical methods for trace-concentration VOC analysis. The focus of this paper is to describe briefly the techniques for making VOC measurements in breath, to present some specific applications for which these methods are relevant, and to demonstrate how to estimate exposure to example VOCs on the basis of breath elimination. We present data from three different exposure scenarios: (a) vinyl chloride and cis-1,2-dichloroethene from showering with contaminated water from a private well, (b) chloroform and bromodichloromethane from high-intensity swimming in chlorinated pool water, and (c) trichloroethene from a controlled exposure chamber experiment. In all cases, for all subjects, the experiment is the same: preexposure breath measurement, exposure to halogenated VOC, and a postexposure time-dependent series of breath measurements. Data are presented only to demonstrate the use of the method and how to interpret the analytical results.
The presence of specific compounds in human blood can indicate a recent exposure (or biological response) to a drug or an environmental pollutant, or indicate a disease state of the individual. The direct measurement of blood for various substances and biomarkers is one of the primary medical diagnostic tools in current use. Because the organic constituents of exhaled human breath are representative of their blood-borne concentrations through gas exchange in the blood/breath interface in the lungs, a breath measurement could conceivably replace a direct blood measurement. A classic example of this is the "breathalyzer" test for inebriation from ethanol [1] . A more recent example is an automated clinical instrument developed for assaying carboxyhemoglobin in blood through measurement of carbon monoxide in end-tidal breath [2] .
For volatile organic compounds (VOCs), sampling and analysis of breath is preferred to direct measurement from blood samples because breath collection is noninvasive, potentially infectious waste is avoided, and the measurement of gas-phase analytes is much simpler in a gas matrix rather than a complex biological tissue such as blood. 1 To exploit these advantages for the assessment of exposure to environmental pollutants, the US Environmental Protection Agency (EPA), academic research institutions, and the medical community have been studying The information in this document, funded by the EPA, has been subjected to Agency review and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.
Received September 25, 1996; revised December 20, 1996; accepted December 24, 1996. 1 Nonstandard abbreviations: VOCs, volatile organic compounds; EPA, Environmental Protection Agency; GC-MS, gas chromatography-mass spectrometry; SBC, single breath canister; QA, quality assurance; and QC, quality control.
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exhaled breath with a variety of sampling and analytical methods. An overview of such work is available in recent review articles by Wallace et al. [3, 4] ; a more general history of the use of breath measurement in medicine has been written by Phillips [5] .
For a given scenario or human activity, a pre-and postset of breath samples is sufficient to confirm the occurrence of an exposure to specific VOCs. To quantify the exposure and to glean additional information regarding residence time in the body, a series of postexposure breath samples can describe the time-dependent elimination of the VOC from the subject and thus be used to infer total body burden and the distribution of target chemicals in the blood and other body tissues. Some examples of this approach and the attendant theory can be found in the literature [6 -9] . Clearly one of the critical issues in the use of elimination kinetics is the collection of samples in an appropriate time frame. For example, the residence times of VOCs in blood are on the scale of a few minutes, so to properly model this behavior requires a series of samples collected rapidly after an exposure. Second, the sample should preferably consist of alveolar air, i.e., expired breath involved in the blood gas interface deep in the alveoli with minimal contribution from the tracheal dead volume.
To address these concerns, we have developed a simple, direct collection method for individual alveolar breath samples and adapted conventional gas chromatography-mass spectrometry (GC-MS) analytical methods for trace-concentration VOC analysis. The "single breath canister" (SBC) sampling method is based on direct exhalation of alveolar air into a 1-L volume stainless steel canister with an internally passivated surface. The SBC technique requires minimal instruction for an untrained subject, is self-administered, and can (in theory) be used to collect individual samples of adjacent breaths; a 30-s sample-to-sample time frame was found to be the practical limit. Subsequent analysis is performed in the laboratory with GC-MS methods especially modified to accommodate the 1-L samples and the high concentrations of water and carbon dioxide in breath. Refs. 10 and 11 present the detailed sampling and analytical procedures (which are beyond the scope of this paper) as well as brief discussions and listings of other relevant studies concerning exhaled breath measurement.
Here we briefly describe the sampling method and present some examples of exhaled breath measurement as a diagnostic tool for determining exposure to microenvironmental pollutants. Specifically, we use the same experimental procedures to explore three different scenarios. The SBC method is used to objectively demonstrate the occurrence and relative magnitude of a recent exposure and to show how the resulting breath concentration vs elimination time data can be interpreted to estimate the magnitude and duration of the resulting blood-borne dose. Individual demonstrations of different scenarios were performed on a few subjects in the realm of methods development for sampling and analysis. As such, no generic interpretation of typical exposures can (or should) be made, nor can we interpret biological responses in context of body type, sex, or age. The intent is to demonstrate the SBC breath measurement method as a tool for exposure assessment, and, by inference, to future clinical applications.
Materials and Methods human subjects
In each scenario, the breath component was a part of a larger study and affected a subset of all human subjects. Subjects were volunteers who gave informed consent and were recruited and selected under institutional procedures by the respective lead organizations: In total, we collected a variety of breath samples from 17 healthy adult subjects who were exposed in the various scenarios (9 men, 8 women, ages 22 to 42). Detailed elimination studies were performed on a subset of 10 subjects for demonstration of the SBC techniques.
sampling equipment and procedures
The sampling apparatus consists of an evacuated 1-L canister fitted with a small Teflon tube used as a mouthpiece as shown in Fig. 1 . The subject closes her lips on the tube, and as she exhales, she opens the canister valve and the breath is collected, filling the evacuated volume. The subject is instructed and trained to begin sample collection at the "bottom" (or end) of a normal resting tidal breath to achieve an alveolar sample. The tracheal dead volume is expelled before the canister sample valve is opened. We note that the typical "at rest" tidal volume is ϳ500 mL and the typical dead volume is ϳ150 mL; as such, the expiratory reserve volume that is collected is as close as possible to purely alveolar. An investigation of the alveolar nature of an SBC sample in contrast to other techniques is available in ref. 10 . Fig. 2 depicts a subject self-administering a sample collection. The SBC method can be used to collect a timed series of samples easily with 30-s sample-to-sample resolution as described in detail in ref. 10 . The canisters used were from two commercial manufacturers, Scientific Instrumentation Specialists, Moscow, ID, and Biospherics, Hillsboro, OR. They are constructed of 306 stainless steel with internal surfaces passivated with an electropolishing technique generally referred to as the "SUMMA " process. Although the breath samples were all collected in 1-L volume canisters, microenvironmental samples (where volume is noncritical) were collected in a variety of canister types including 1.8-, 2.8-, 3-, and 6-L volumes, subject to availability. Both "integrated" whole-air samples (averages over a specific time period) and "grab" whole-air samples were used to assess the inspired air during and after the exposures.
analytical equipment and procedures
Although subsequent laboratory analysis can be performed with any of a variety of GC-MS methods for air, for our purposes here, the standard EPA Method TO-14 [12] and the concentrator equipment were somewhat modified to accommodate some of the more reactive species found in exhaled breath; this is described in detail in ref. 11. For some quality-assurance (QA) analyses, where the compound(s) of interest allowed, the standard TO-14 method and commercially available instrumentation were also used. Briefly, each breath sample is transported to the laboratory, pressurized with a neutral gas, and a dilution factor is calculated on the basis of pre-and postpressurization absolute pressure. The analytical instrumentation is fully automated to extract an aliquot from the canister, cryogenically concentrate, thermally desorb/inject onto a capillary column, and then analyze with a mass spectrometer. Samples of microenvironmental air from the exposure area and control samples of inspired air after the exposure were also collected and analyzed with the same equipment. Carbon dioxide assays of breath samples were performed also by GC-MS; however the injection technique was adjusted to use only a tiny (typically 50-L) aliquot via injection loop, or with a short cycle of the "valveless concentrator" as described in ref.
11.
For the Rockford scenario, microenvironmental samples were analyzed with TO-14 methodology with a Nutech 320 -01 cryoconcentrator (Graseby-Nutech, Smyrna, GA) and a Hewlett-Packard GC-MS system GC5880 and MS5970 (Hewlett-Packard, Avondale, PA and Palo Alto, CA, respectively). The GC column was an SPB-1 60 m ϫ 0.32 mm (i.d.) ϫ 1.0 m film thickness (Supelco, Bellefonte, PA). Exhaled breath samples were analyzed with a prototype "valveless concentrator" (patent #5447556) developed under a cooperative research and development agreement (CRADA #0026 -92) between Graseby-Nutech and the EPA that was interfaced to an ITS40 (Magnum) GC-MS ion trap instrument (Finnigan MAT, San Jose, CA). The analytical column was an XTI-5 Quantification was achieved with external calibrators prepared for each sample set for all analytes. System linearity was always confirmed over the sample range with five-point calibration. Daily response factors and system integrity were determined via single-point calibration and canister blanks. A minimum of 25% replicate analyses (of real samples) was performed to continually assess system precision. Calibrators were independently prepared and assessed by our on-site contractor, ManTech Environmental Technology, by using certified calibrators from Alphagaz, Morrisville, PA, and Scott Specialty Gases, Plumsteadville, PA.
data postprocessing and interpretation
Raw GC-MS extracted ion peak area data for analytes of interest were corrected to reflect current calibration response factors. Measurements of carbon dioxide concentrations were then used to assess a subject's data set and used to normalize to a nominal 5% for alveolar breath to assure internal consistency for that subject. For the healthy adult subjects studied in this work, 5% was a reasonable normalizing factor for the "true" alveolar concentration, although this technique may require revision in the case of ill or impaired subjects with pulmonary disorders. Because each subject was seated, calm, and at rest during the sample collection, there was no variability due to exercise or hyperventilation; we used the carbon dioxide correction only as a method to account for slight variations from the sample pressurization step in the laboratory and from the subject's technique in filling the canister. We found through many trials that even the most experienced subject can occasionally entrain some ambient air into the sample, or prematurely close the valve, both of which would result in a dilution of alveolar air in the finally processed sample. In either case, the assay of carbon dioxide provides an accurate correction factor for the overall "alveolar" nature of an individual sample and thus is used to scale the concentration of the analyte to correctly reflect the breath concentration. Issues concerning the assay of carbon dioxide in breath, exercise-and breathing technique-related perturbations, and the consistency of data sets from one individual are discussed in refs. 10 and 11.
Time after exposure vs analyte concentration data were modeled to generate a mathematical approximation of the breath elimination of VOCs. We chose a multiterm exponential decay model by Wallace et al. [7] and applied it to the data with GraphPad Prism (GraphPad Software, San Diego, CA), a nonlinear modeling program optimized for a least-squares fit (no weighting). Specifically, the model takes the form:
where C alveolar (t) is the alveolar breath concentration (g/ m 3 )at any time t (min) during the elimination (t ϭ 0 denotes the end of the exposure); the coefficients A i (g/m 3 ) indicate capacities or contributions from bodily compartments that have elimination time coefficients of k n (1/min); and iC air (g/m 3 ) is the contribution of the inspired air during elimination (in our experiments, iC air ϭ 0). The resulting equation is integrated from time ϭ 0 to infinity, then multiplied by the alveolar breathing rate R (m 3 /min) to establish the mass of contaminant M cont (g) eliminated via exhalation. The resulting quantity takes the form:
which is considered a lower-bound estimate of the total absorbed dose. Note that there may be other mechanisms of elimination such as metabolism, urinary excretion, and dermal losses that are not represented by M cont . Additionally, if Eq. 1 is evaluated at time t ϭ 0, and we have access to the blood/breath partition coefficient P (m 3 /1000 L), we can generate an estimate of the lower bound of the highest blood concentrations caused by the exposure as follows:
This assumes that the exposure is nondecreasing. Finally, the estimated parameters k i from Eq. 1 are used to estimate the half-life t 1 ⁄2i (min) of the contaminant in the "ith" modeled bodily compartment by:
Although detailed pharmacokinetics would be required to legitimately assign the "ith" term of Eq. 1 to a specific biological system or compartment, we generally consider the 1st term to represent the blood, the 2nd "highly perfused tissues" (liver, other organs, some muscle), the 3rd "moderately perfused tissues" (muscle, organs, liquid reservoirs), and the 4th "poorly perfused tissues" (adipose and connective tissue). Some well-known examples of pharmacokinetic modeling of VOCs and interpretations of bodily compartments are listed in the references [8, 9, [13] [14] [15] .
Results and Discussion
In all cases the instrumentation performed better than 6% replicate precision (CV) on synthetic breath calibrators and working calibrators across a dynamic range that included the real data. For the Rockford and Montana sample sets, carbon dioxide assays resulted in a typical replicate precision of 2-3%. Because of unavoidable instrument changes, controlled QA/quality-control (QC) tests resulted in a CV of 4 -5% for carbon dioxide measurements for the Chamber experiment. Analyses of ambient (inspired) air during the elimination portion of each experiment confirmed concentrations of halogenated VOC analytes below the concentration of quantification for each experiment. For the Rockford and Montana scenarios, the subjects were physically removed from the exposure area; for the "Chamber" work, hospital-grade air and individual free-flowing masks were used for inspired air until the chamber had been cleared. Exposure parameters for the three experiments are given in Table 1 . These include the compound name, the duration of the exposure, the measured average values for the air concentration, and the water concentration. Note that a variety of sequences are represented: short-term, low-concentration; moderate-term, low-and moderateconcentration; and long-term, high-concentration. Also, we have included conversion equivalency between mol/L and g/L for the compounds of interest for reference. Table 2 presents the numeric values for the parameters that result in the best nonlinear least-squares fit for each data set for the exponential elimination function as described in Eq. 1. Each data set is identified by the experiment name, subject/experiment identification code, and compound measured; the number of measurements and elimination times are given to assist interpretation of the model parameters. The number of compartments (or exponential terms) most appropriate to the data set was empirically determined with a "residuals runs" analysis to set the lower limit, and occurrence of redundant terms to set the upper limit. For these data, a time frame Ͼ2 h is necessary to be able to mathematically discern the elimination from the 3rd compartment. In all cases the model fit to the concentration data was excellent, with most R 2 test limits Ͼ0.99.
Graphs of representative data of VOC elimination from each experiment are presented in Fig. 3 . Fig. 3A -C shows data and model for R1ABL1 (vinyl chloride) and R1ABL2 Clinical Chemistry 43, No. 5, 1997 (cis-1,2-dichloroethene) as an example of a short-term, low-concentration exposure; M1FMS1 (bromodichloromethane) and M1FMS2 (chloroform) as an example of moderate-term, low-and moderate-concentration exposure; and C3F110 and C3M210 (trichloroethene) as examples of long-term, high-concentration exposure, respectively. Table 3 documents the calculated biological parameters as described in Materials and Methods. For the lowerbound estimate of the total dose, M cont , as described in Eq. 2, we used a conservative breathing rate estimate of 0.007 m 3 /min (7 L/min). For the estimates of the highest blood concentration generated by the exposure (see Eq. 3), we used blood/breath partition coefficients published by Gargas et al. [16] : 1.16 for vinyl chloride, 9.85 for cis-1,2-dichloroethene, 6.85 for chloroform, and 8.11 for trichloroethene. Though unavailable in the literature, we estimated the partition coefficient for bromodichloromethane at 29.9 through interpolation of coefficient vs boiling point for trihalomethanes.
Note that even for a brief 10-min shower exposure of 25 g/m 3 (inhalation) and 4 g/L (dermal contact in water), we calculate 0.9 g absorbed dose of vinyl chloride and a blood concentration of 0.01 g/L. The 2-h swimming pool exposure (for trained athletes) resulted in an estimated dose of 100 g and a blood concentration of ϳ2 g/L. The 4-h exposure to 100 ppmv (550 000 g/m 3 ) of trichloroethene,which (for comparison) represents half of the integrated Occupational Safety and Health Administration permissible exposure limit of 100 ppm for occupational exposure for an 8-h workshift [17] , resulted in estimated absorbed doses from 23 to 90 mg with peak blood concentrations averaging ϳ1200 g/L.
Calculated half-lives (as defined in Eq. 4) in the 1st compartment (blood) were calculated from 0.5 to 4 min, the 2nd compartment (highly perfused tissues) from 8 to 62 min, and the 3rd compartment (moderately perfused tissues) from 1.5 to 19 h across all subjects and all types of exposures to halogenated VOCs.
Overall, these experiments gave reasonable estimates of absorbed dose and blood concentrations in line with the cited literature. Critical examination of the timedependence of the elimination curves as graphed in Fig. 3 and the model results in Tables 2 and 3 show that the first few minutes after the exposure are critical in estimating the dose and peak blood concentration because the breath concentration is decreasing by half in the first 1-2 min. Gathering representative data during this time is complicated by several factors. First, it is experimentally difficult to assign a precise time (t ϭ 0) for when the elimination begins because some time does elapse during the transition of the subject from exposure to "clean" air. Second, the physical movement of the subject and the increased activity associated with sample collection tend to affect the ventilation rate during this time and may perturb the "alveolar" nature of the sample. Finally, the logistics of collecting a quick series of samples in a few minutes require some coordination of effort in sample container handling and records keeping. The behavior of the "slow- Example breath elimination data and models from (A) Rockford experiment for 10-min-long shower exposure to cis-1,2-dichloroethene and vinyl chloride; (B) Montana experiment for 2-h-long swimming pool exposure to bromodichloromethane and chloroform; and (C) Chamber experiment for 4-h-long "occupational" exposure to trichloroethene.
er" tissues (2nd and 3rd compartments) is more easily deduced because accurate sample timing is not as critical.
On the basis of the results from these experiments, we are investigating modifications to our techniques to get a more accurate representation of the 1st-compartment elimination. We will experiment with the use of a portable clean-air supply and "on-demand" breathing regulators (modified scuba diving gear) to precisely decouple the exposure period from the elimination period. Second, we will attempt to extend the model into a hypothetical "zeroth" compartment that could be considered a very fast, low-capacity compartment comprising the mucous membranes of the mouth and tracheal airway by collecting adjacent breaths during the first 30 s of the elimination time.
The analysis of exhaled breath is an excellent exposure assessment tool for halogenated VOCs that can unambiguously demonstrate that an exposure has occurred, and with a time series of samples after the exposure, gives the possibility of modeling the washout of the contaminant from the body. The appropriate multiterm exponential decay model has been used to establish approximate residence times for pollutants in the body, and also to estimate minimum blood concentrations and integrated dose, all without an invasive medical procedure. The techniques presented here could be extended to the broader clinical setting where the analyte could be a volatile bioresponse marker for a disease state, for an administered drug or anesthetic, or for changes subsequent to a medical procedure. Future work should focus on individual differences among a statistically significant number of subjects sorted by body type, sex, and age to further develop the method for eventual mainstream clinical use. For conversion factors, see Table 1 .
